NSIM
BIO icon

North Star Investment Management’s Bio-Rad Laboratories Class A BIO Stock Holding History

North Star Investment Management’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-1
Closed -$358 – 1209
2023
Q3 		$358 Hold
1
– – ﹤0.01% 1220
2023
Q2 		$379 Hold
1
– – ﹤0.01% 1234
2023
Q1 		$479 Hold
1
– – ﹤0.01% 1240
2022
Q4 		$420 Buy
+1
New +$404 ﹤0.01% 1247

Other funds holding BIO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VAM
Veritas Asset Management London, United Kingdom $5.9B AUM 3.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return

North Star Investment Management's BIO Position: Q4 2023 in Review

North Star Investment Management sold out of Bio-Rad Laboratories Class A (BIO) in Q4 2023, closing a stake of 1 share — an estimated $358 sold.

North Star Investment Management first reported a position in BIO in Q4 2022 and held it in 4 quarters. The position peaked at $479 in Q1 2023. 484 funds tracked by Wall St. Rank hold BIO as of Q4 2023.

  • North Star Investment Management reported no remaining Bio-Rad Laboratories Class A position as of Q4 2023 after selling out during the quarter.
  • North Star Investment Management sold 1 Bio-Rad Laboratories Class A share in Q4 2023, an estimated $358.
  • North Star Investment Management first reported a position in Bio-Rad Laboratories Class A in Q4 2022 and held it in 4 quarters.
  • North Star Investment Management's Bio-Rad Laboratories Class A position peaked at $479 in Q1 2023.
  • 484 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q4 2023.

Based on North Star Investment Management's 13F filing for Q4 2023, filed 10 Jan 2024.